Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pfizer to supply Sutent for immatics' phase III IMA-901 trial in advanced renal cell cancer

April 12, 2011

Sumitomo Chemical designs new inhibitors of 17-beta-HSD 3

April 12, 2011

Novartis discontinues phase III Tasigna trial in gastrointestinal stromal tumors

April 11, 2011

Champions Oncology exercises option to license Irinophore C

April 11, 2011

Livatag improves survival of patients with advanced hepatocellular carcinoma

April 11, 2011

Frizzled SMO receptor inhibitor LY-2940680 exhibits antitumor effects in vivo

April 11, 2011

Novel PLK4 inhibitors demonstrate antiproliferative activity in models of breast cancer

April 11, 2011

Marina Biotech advances phase Ib/IIa trial of CEQ-508 in FAP

April 8, 2011

First phase I trial begins for IMC-3C5 in advanced solid tumors

April 8, 2011

Chifcon Medicine R&D describes natural antitumor agents coupled to NO donors

April 8, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...